Purchases and Sales Made in Q4 2024 in Mi Nk Therapeutics, Inc. (INKT)
This table provides information about the institutional ownership of Mi Nk Therapeutics, Inc. (INKT) during Q4 2024. The information is specifically focused on institutions that hold shares of MiNK Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.37K+ 34.12% |
$632 - $1.09K
|
5.4K
$55.6K
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
368+ 3.32% |
$169 - $291
|
11.4K
$118K
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
196+ 151.94% |
$90.2 - $155
|
325
$3.35K
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2- 0.6% |
$0.92 - $1.58
|
334
$3.44K
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-454- 4.31% |
$209 - $359
|
10.1K
$104K
|
|
Feb 07, 2025
Q4 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-1.05K- 2.03% |
$484 - $831
|
50.7K
$522K
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-1.87K- 1.91% |
$859 - $1.48K
|
96.1K
$990K
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-3.37K- 54.17% |
$1.55K - $2.66K
|
2.85K
$29.3K
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-4.98K- 4.67% |
$2.29K - $3.93K
|
102K
$1.05M
|